World News
Business
Investing
Stocks

World News
Business
Investing
Stocks

Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

June 4, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post

Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah

next post

Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

ARR advances permitting at Cowboy State Mine

May 28, 2025

Finlay Minerals Appoints an Executive Chairman, President &...

May 13, 2025

Sranan Gold: Unlocking Suriname’s Next Multi-Million-Ounce Discovery in...

July 30, 2025

Group Eleven Intersects 12.0m of 2.30% Cu and...

May 8, 2025

Mobile Gaming Stocks: 10 Biggest Companies in 2025

June 17, 2025

Crypto Market Recap: Circle, Klarna and Chime May...

April 5, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Popular

1

First the token, now the swipe: NYC’s subway system to stop selling MetroCards
March 20, 2025
2

AI that can match humans at any task will be here in five to 10 years, Google DeepMind CEO says
March 19, 2025
3

How new professional sports leagues like SailGP are putting women at the fore
March 21, 2025
4

Plummeting stock, boycotts and flagging sales: What’s fueling turmoil for Tesla?
March 18, 2025
5

Lebanon says it was hit by cross-border attack from Syria as tensions escalate
March 18, 2025

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 insiderfinancenews.com | All Rights Reserved